Biodesix (BDSX) News Today $0.34 -0.01 (-3.74%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.35 +0.01 (+1.58%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BDSX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Scotiabank Lowers Biodesix (NASDAQ:BDSX) Price Target to $2.00May 24 at 1:31 AM | americanbankingnews.comBiodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual MeetingMay 22 at 5:03 PM | globenewswire.comBiodesix to Participate in Upcoming Investor ConferencesMay 21, 2025 | globenewswire.comWilliam Blair Predicts Biodesix's Q2 Earnings (NASDAQ:BDSX)May 18, 2025 | americanbankingnews.comBiodesix (NASDAQ:BDSX) Price Target Cut to $1.50 by Analysts at Craig HallumMay 17, 2025 | americanbankingnews.comWilliam Blair Reiterates Market Perform Rating for Biodesix (NASDAQ:BDSX)William Blair reaffirmed a "market perform" rating on shares of Biodesix in a research note on Wednesday.May 16, 2025 | marketbeat.comLake Street Capital Issues Pessimistic Forecast for Biodesix (NASDAQ:BDSX) Stock PriceMay 16, 2025 | americanbankingnews.comBiodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATSMay 15, 2025 | globenewswire.comDenver Post Names Biodesix a Winner of Top Workplaces 2025 AwardMay 14, 2025 | globenewswire.comBiodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call TranscriptMay 14, 2025 | insidermonkey.comBiodesix, Inc. (BDSX) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comBiodesix Announces First Quarter 2025 Results and HighlightsMay 13, 2025 | globenewswire.comSusquehanna International Group LLP Acquires 987,475 Shares of Biodesix, Inc. (NASDAQ:BDSX)Susquehanna International Group LLP boosted its holdings in Biodesix, Inc. (NASDAQ:BDSX - Free Report) by 769.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,115,748 shares of the company's stock after purchasinMay 13, 2025 | marketbeat.comFarallon Capital Management LLC Sells 825,365 Shares of Biodesix, Inc. (NASDAQ:BDSX)Farallon Capital Management LLC lessened its position in Biodesix, Inc. (NASDAQ:BDSX - Free Report) by 17.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,811,426 shares of the company's stock after selling 825,365 shares dMay 11, 2025 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Buy" from AnalystsShares of Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) have been given an average rating of "Buy" by the five analysts that are currently covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average twelve-month price objective amMay 1, 2025 | marketbeat.comCanaccord Genuity Group Issues Pessimistic Forecast for Biodesix (NASDAQ:BDSX) Stock PriceCanaccord Genuity Group reduced their target price on shares of Biodesix from $3.50 to $2.50 and set a "buy" rating for the company in a research note on Tuesday.May 1, 2025 | marketbeat.comBiodesix to Report First Quarter 2025 Financial Results on May 13, 2025April 29, 2025 | globenewswire.comSilverarc Capital Management LLC Has $6.63 Million Stock Position in Biodesix, Inc. (NASDAQ:BDSX)Silverarc Capital Management LLC boosted its stake in Biodesix, Inc. (NASDAQ:BDSX - Free Report) by 21.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,332,281 shares of the company'sApril 24, 2025 | marketbeat.comBiodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor typesApril 23, 2025 | globenewswire.comSamjo Management LLC Makes New $3.79 Million Investment in Biodesix, Inc. (NASDAQ:BDSX)Samjo Management LLC purchased a new stake in Biodesix, Inc. (NASDAQ:BDSX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 2,477,400 shares of the company's stock, valued at approximately $3,790,000. BioApril 7, 2025 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Short Interest Up 29.5% in MarchBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,260,000 shares, a growth of 29.5% from the February 28th total of 973,200 shares. Based on an average trading volume of 417,700 shares, the short-interest ratio is currently 3.0 days. Currently, 2.8% of the shares of the company are sold short.April 1, 2025 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Shares Acquired by AIGH Capital Management LLCAIGH Capital Management LLC increased its holdings in shares of Biodesix, Inc. (NASDAQ:BDSX - Free Report) by 8.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,179,812 shares of the company's stock aftMarch 31, 2025 | marketbeat.comPerkins Capital Management Inc. Increases Holdings in Biodesix, Inc. (NASDAQ:BDSX)Perkins Capital Management Inc. grew its stake in Biodesix, Inc. (NASDAQ:BDSX - Free Report) by 46.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,060,211 shares of the company's stock after acquirinMarch 25, 2025 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in FebruaryBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 973,200 shares, a growth of 24.6% from the February 13th total of 781,300 shares. Approximately 2.2% of the company's shares are sold short. Based on an average daily volume of 428,500 shares, the short-interest ratio is currently 2.3 days.March 17, 2025 | marketbeat.comWhat is William Blair's Forecast for Biodesix Q1 Earnings?Biodesix, Inc. (NASDAQ:BDSX - Free Report) - Equities researchers at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Biodesix in a research note issued to investors on Tuesday, March 4th. William Blair analyst A. Brackmann anticipates that the company will earnMarch 7, 2025 | marketbeat.comResearch Analysts Set Expectations for Biodesix Q1 EarningsBiodesix, Inc. (NASDAQ:BDSX - Free Report) - Equities researchers at William Blair issued their Q1 2026 earnings estimates for Biodesix in a research report issued to clients and investors on Tuesday, March 4th. William Blair analyst A. Brackmann forecasts that the company will post earnings of (March 6, 2025 | marketbeat.comScotiabank Keeps Their Buy Rating on Biodesix (BDSX)March 5, 2025 | markets.businessinsider.comBiodesix reports Q4 EPS (6c) vs. (10c) last yearMarch 4, 2025 | markets.businessinsider.comBiodesix (NASDAQ:BDSX) Earns "Outperform" Rating from William BlairWilliam Blair reaffirmed an "outperform" rating on shares of Biodesix in a report on Tuesday.March 4, 2025 | marketbeat.comBiodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025March 4, 2025 | insidermonkey.comBiodesix, Inc. (BDSX) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | seekingalpha.comBiodesix (NASDAQ:BDSX) Posts Earnings Results, Beats Estimates By $0.01 EPSBiodesix (NASDAQ:BDSX - Get Free Report) issued its earnings results on Monday. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. Biodesix had a negative net margin of 66.84% and a negative return on equity of 275.79%.March 3, 2025 | marketbeat.comBiodesix Announces Fourth Quarter and Fiscal Year 2024 ResultsMarch 3, 2025 | globenewswire.comBiodesix to Present at TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comBiodesix (BDSX) Expected to Announce Earnings on MondayBiodesix (NASDAQ:BDSX) will be releasing earnings after the market closes on Monday, March 3. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=667161)February 24, 2025 | marketbeat.comBiodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025February 18, 2025 | globenewswire.comBiodesix, Inc. (NASDAQ:BDSX) Insider Sells $15,408.16 in StockFebruary 13, 2025 | insidertrades.comInsider Selling: Biodesix, Inc. (NASDAQ:BDSX) Insider Sells 16,748 Shares of StockBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) insider Gary Anthony Pestano sold 16,748 shares of the stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $0.92, for a total value of $15,408.16. Following the sale, the insider now directly owns 156,008 shares of the company's stock, valued at approximately $143,527.36. This trade represents a 9.69 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.February 12, 2025 | marketbeat.comRobin Harper Cowie Sells 24,664 Shares of Biodesix, Inc. (NASDAQ:BDSX) StockBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) CFO Robin Harper Cowie sold 24,664 shares of Biodesix stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $0.92, for a total value of $22,690.88. Following the completion of the sale, the chief financial officer now owns 246,460 shares of the company's stock, valued at approximately $226,743.20. The trade was a 9.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.February 12, 2025 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) CEO Scott Hutton Sells 83,660 SharesBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) CEO Scott Hutton sold 83,660 shares of the stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $0.92, for a total transaction of $76,967.20. Following the completion of the sale, the chief executive officer now directly owns 701,947 shares of the company's stock, valued at $645,791.24. This trade represents a 10.65 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.February 12, 2025 | marketbeat.comShort Interest in Biodesix, Inc. (NASDAQ:BDSX) Declines By 7.4%Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 836,600 shares, a drop of 7.4% from the December 31st total of 903,100 shares. Based on an average trading volume of 420,900 shares, the short-interest ratio is presently 2.0 days.February 1, 2025 | marketbeat.comShort Interest in Biodesix, Inc. (NASDAQ:BDSX) Drops By 7.4%Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 836,600 shares, a decrease of 7.4% from the December 15th total of 903,100 shares. Based on an average daily volume of 420,900 shares, the short-interest ratio is presently 2.0 days.January 18, 2025 | marketbeat.comLake Street Sticks to Their Buy Rating for Biodesix (BDSX)January 10, 2025 | markets.businessinsider.comCraig-Hallum Gives a Buy Rating to Biodesix (BDSX)January 10, 2025 | markets.businessinsider.comBiodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)January 10, 2025 | globenewswire.comBiodesix Announces Publication of a New Nodify CDT® Clinical Validation StudyJanuary 7, 2025 | globenewswire.comShort Interest in Biodesix, Inc. (NASDAQ:BDSX) Expands By 44.7%Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 903,100 shares, an increase of 44.7% from the November 30th total of 624,200 shares. Based on an average daily trading volume, of 395,100 shares, the short-interest ratio is presently 2.3 days.December 28, 2024 | marketbeat.comWilmington Savings Fund Society FSB Takes Position in Biodesix, Inc. (NASDAQ:BDSX)Wilmington Savings Fund Society FSB acquired a new position in Biodesix, Inc. (NASDAQ:BDSX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 6,095,034 shares of the company's stock, valued at approximately $10,849,00December 12, 2024 | marketbeat.comBiodesix, Inc. (BDSX)November 24, 2024 | finance.yahoo.comInsider Buys Additional US$234k In Biodesix StockNovember 23, 2024 | uk.finance.yahoo.com Get Biodesix News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter. Email Address BDSX Media Mentions By Week BDSX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDSX News Sentiment▼-0.500.75▲Average Medical News Sentiment BDSX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDSX Articles This Week▼61▲BDSX Articles Average Week Get Biodesix News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DCGO News Today EUDA News Today XGN News Today CORBF News Today ATPC News Today SERA News Today KDLY News Today QIPT News Today PIII News Today CCM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BDSX) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodesix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodesix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BDSX Stock Free BDSX Stock Alerts